Additional European Equity News

AstraZeneca (AZN LN) - Lynparza and Imfinzi combination improved progression-free survival in newly diagnosed patients with advanced ovarian cancer without tumour BRCA mutations in DUO-O Phase III trial. (AstraZeneca)

Barratt Developments (BDEV LN) - Co. announced that it purchased and cancelled a number of its own shares from Credit Suisse International (CSGN SW) as part of its GBP 200mln share repurchase program. The shares were purchased through an "on exchange" transaction that was subject to the rules of the LSE. This is the third tranche of the share repurchase program which was announced in September 2022. (Barratt Developments)

Centrica (CNA LN) - Co. has started the previously announced GBP 300mln share buyback programme. (Newswires) 

Entain (ENT LN) - Co. acquired 365Scores for USD 150mln. (Newswires)

Healthcare Names - Johnson & Johnson (JNJ) - Rose over 3% after hours, after it announced that it will pay USD 8.9bln to resolve current and future talc claims.

MorphoSys (MOR GY) - Completes enrolment of phase 3 MANIFEST-2 study of pelabresib in myelofibrosis with topline results expected by end of 2023. (Yahoo Finance), Shares seen +2.7%

Nexans (NEX FP) - Sales of 4.2mln shares via a private placement to institutional investors, Invexans remains core shareholder though its stake is reduced. (Newswires)

UBS (UBSG SW) - UBS AGM to begin today at 09:00BST/04:00EDT. (Credit Suisse/UBS).

Telecom Italia (TIT IM) - KKR has reportedly requested a EUR 10.5bln loan from banks with the intention of improving its offer for Telecom Italia's network grid, via Il Messaggero. (Newswires)

TotalEnergies (TTE FP) - Co. has confirmed the Iraq deal flagged on Tuesday. (Newswires) Yesterday, sources suggested Baghdad to take a 30% stake in TotalEnergies' USD 27bln Iraq energy project.

Atlas Copco (ATCOA SS) upgraded to Buy from Hold at Handelsbanken

K+S (SDF GY) downgraded to Hold from Buy at Stiefel Nicolaus

05 Apr 2023 - 07:03- EquitiesResearch Sheet- Source: Newsquawk